-
The mesalamine wars heat up-enter balsalazide.
PMID: 12557164 [PubMed - indexed for MEDLINE]
-
Related articles
-
A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis.
Am J Gastroenterol. 2002 Jun; 97(6):1398-407.
[Am J Gastroenterol. 2002]
-
Treatment of ulcerative colitis with balsalazide: response to Drs Johnson, Green, and Pruitt.
Am J Gastroenterol. 2003 Mar; 98(3):697-8.
[Am J Gastroenterol. 2003]
-
ReviewEquimolar doses of balsalazide and mesalamine: are we comparing apples and oranges?
Am J Gastroenterol. 2002 Jun; 97(6):1283-5.
[Am J Gastroenterol. 2002]
-
Oral balsalazide (Colazal) for ulcerative colitis.
Med Lett Drugs Ther. 2001 Jul 23; 43(1109):62-3.
[Med Lett Drugs Ther. 2001]
-
ReviewTreatment of ulcerative colitis with oral mesalamine: advances in drug formulation, efficacy expectations and dose response, compliance, and chemoprevention.
Rev Gastroenterol Disord. 2006 Spring; 6(2):97-105.
[Rev Gastroenterol Disord. 2006]
- » See reviews... | » See all...
Patient Drug Information
-
Mesalamine (Asacol® , Canasa® , Pentasa® , ...)
Mesalamine is used to treat ulcerative colitis (a condition in which part or all of the lining of the colon [large intestine] is swollen or worn away). Mesalamine delayed-release tablets and controlled-release capsules m...
-
Balsalazide (Colazal® )
Balsalazide is used to treat ulcerative colitis, a condition in which the bowel is inflamed. Balsalazide is an anti-inflammatory drug. It is converted in the body to mesalamine and works by reducing bowel inflammation, d...